Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
International Journal of Clinical and Experimental Pathology|August 15, 2014
Clinicopathological features of hepatitis B virus recurrence after liver transplantation: eleven-year experienceDonghong Zhang, Zuoyi Jiao, Jixiang Han, et al.
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|July 12, 2014
[Meta-analysis of total thyroidectomy for multinodular goiter]Hongtai Cao, Jixiang Han, Donghong Zhang, et al.
Frontiers in Microbiology|July 2, 2026
Characterization of the gastric mucosal microbiota in tumoral and peritumoral mucosa in patients with advanced gastric cancer from Northwest ChinaHongtai Cao, Qi Wang, Wen Ren, et al.
Molecular Carcinogenesis|August 20, 2025
Targeting Posttranslational Modifications in the Tumor Stromal Microenvironment for Antitumor TherapyHuiguo Qing, Xiangyan Jiang, Yong Ma, et al.
International Journal of Surgery (London, England)|June 26, 2018
Clinical characteristics and prognostic significance of galectins for patients with gastric cancer: A meta-analysisBo Long, Zeyuan Yu, Huinian Zhou, et al.
Bioorganic Chemistry|January 7, 2023
Ac<sub>3</sub>4FGlcNAz is an effective metabolic chemical reporter for O-GlcNAcylated proteins with decreased S-glyco-modificationJiajia Wang, Wei Cao, Wei Zhang, et al.
Oncotarget|April 22, 2017
UBE2T knockdown inhibits gastric cancer progressionChangjiang Luo, Yunyi Yao, Zeyuan Yu, et al.
Journal of Experimental & Clinical Cancer Research : CR|January 3, 2025
Gastric cancer-derived exosomal let-7 g-5p mediated by SERPINE1 promotes macrophage M2 polarization and gastric cancer progressionZhenzhen Ye, Jianfeng Yi, Xiangyan Jiang, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 20, 2024
EGCG targeting STAT3 transcriptionally represses PLXNC1 to inhibit M2 polarization mediated by gastric cancer cell-derived exosomal miR-92b-5pJianfeng Yi, Zhenzhen Ye, Hao Xu, et al.
Journal for Immunotherapy of Cancer|June 8, 2026
Targeting ATF4 overcomes dual resistance to chemo-immunotherapy in gastric cancer by disrupting the DNA damage responseHuili Ye, Wentao Zhang, Hongtai Cao, et al.
Pageof 2